Advertisement

Therapy in Pregnancy

  • Yuji YamadaEmail author
  • Yoshitaka Miyakawa
Chapter

Abstract

Glucocorticoids and intravenous immunoglobulins are widely accepted and recommended in guidelines for the treatment in pregnancy. On the other hand, the safety profile of the other options during pregnancy is not well known. Since ITP affects not only pregnant women but also neonates, the effective communication among hematologists, obstetricians, and pediatricians should be established for efficient management.

Keywords

Pregnant Woman Inflammatory Bowel Disease Platelet Count Laparoscopic Splenectomy Starting Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol. 2000;37(3):275–89.CrossRefPubMedGoogle Scholar
  2. 2.
    Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–86.CrossRefPubMedGoogle Scholar
  3. 3.
    Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–207.CrossRefPubMedGoogle Scholar
  4. 4.
    British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120(4):574–96.CrossRefGoogle Scholar
  5. 5.
    Miyakawa Y. [Consensus report on the management of immune thrombocytopenia in pregnancy]. Rinsho Ketsueki 2015; 56(10):2086–91.Google Scholar
  6. 6.
    Fujimura K, Harada Y, Fujimoto T, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 2002;75(4):426–33.CrossRefPubMedGoogle Scholar
  7. 7.
    Erkman J, Blythe JG. Azathioprine therapy complicated by pregnancy. Obstet Gynecol. 1972;40(5):708–10.PubMedGoogle Scholar
  8. 8.
    Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99(2):443–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2017

Authors and Affiliations

  1. 1.Department of MedicineMount Sinai Beth IsraelNew YorkUSA
  2. 2.Department of General Internal MedicineCenter for Thrombosis and Hemostasis, Saitama Medical UniversitySaitamaJapan

Personalised recommendations